Cancer is characterised by uncontrolled proliferation and inappropriate cell survival3 and these processes are commonly enhanced in tumours by up-regulation of the PI3K/Akt/mTOR pathway frequently as a result of over-expression of upstream receptors or mutations in components of the pathway or both. This evidence concerns the gene MTOR and cancer.